Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

[Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].

Rambour M, Moreau C, Salleron J, Devos D, Kreisler A, Mutez E, Simonin C, Annic A, Dujardin K, Destée A, Defebvre L.

Rev Neurol (Paris). 2014 Mar;170(3):205-15. doi: 10.1016/j.neurol.2013.10.012. Epub 2014 Mar 1. French.

PMID:
24594365
2.

[Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications].

Giménez de Béjar V, Carballo-Cordero M.

Rev Neurol. 2012;55 Suppl 1:S25-9. Spanish.

PMID:
23169230
3.

Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients.

Borgemeester RW, Drent M, van Laar T.

Parkinsonism Relat Disord. 2016 Feb;23:17-22. doi: 10.1016/j.parkreldis.2015.11.013. Epub 2015 Nov 22.

PMID:
26709292
4.

[Candidate patient for treatment with continuous apomorphine infusion].

Martí MJ, Kulisevsky J.

Rev Neurol. 2012;55 Suppl 1:S15-9. Review. Spanish.

PMID:
23169228
5.

Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years.

Morgante L, Basile G, Epifanio A, Spina E, Antonini A, Stocchi F, Di Rosa E, Martino G, Marconi R, La Spina P, Nicita-Mauro V, Di Rosa AE.

Arch Gerontol Geriatr Suppl. 2004;(9):291-6.

PMID:
15207426
7.

[Subcutaneous continuous apomorphine infusion: treatment initiation and follow up].

Grandas FJ, Sesar-Ignacio Á.

Rev Neurol. 2012;55 Suppl 1:S21-4. Review. Spanish.

PMID:
23169229
8.

Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.

Deleu D, Hanssens Y, Northway MG.

Drugs Aging. 2004;21(11):687-709. Review.

PMID:
15323576
9.

Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort study.

Drapier S, Eusebio A, Degos B, Vérin M, Durif F, Azulay JP, Viallet F, Rouaud T, Moreau C, Defebvre L, Fraix V, Tranchant C, Andre K, Courbon CB, Roze E, Devos D.

J Neurol. 2016 Jun;263(6):1111-9. doi: 10.1007/s00415-016-8106-3. Epub 2016 Apr 8.

PMID:
27060084
10.

Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.

Pietz K, Hagell P, Odin P.

J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):709-16.

11.

[Apomorphine in treatment of Parkinson's disease with fluctuations].

Zaleska B, Domzał T.

Neurol Neurochir Pol. 1999 Nov-Dec;33(6):1297-303. Polish.

PMID:
10791032
12.

Use of apomorphine in Parkinson's disease.

Stocchi F.

Neurol Sci. 2008 Dec;29 Suppl 5:S383-6. doi: 10.1007/s10072-008-1053-8. Review.

PMID:
19381769
13.
14.

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study.

García Ruiz PJ, Sesar Ignacio A, Ares Pensado B, Castro García A, Alonso Frech F, Alvarez López M, Arbelo González J, Baiges Octavio J, Burguera Hernández JA, Calopa Garriga M, Campos Blanco D, Castaño García B, Carballo Cordero M, Chacón Peña J, Espino Ibáñez A, Gorospe Onisalde A, Giménez-Roldán S, Granés Ibáñez P, Hernández Vara J, Ibáñez Alonso R, Jiménez Jiménez FJ, Krupinski J, Kulisevsky Bojarsky J, Legarda Ramírez I, Lezcano García E, Martínez-Castrillo JC, Mateo González D, Miquel Rodríguez F, Mir P, Muñoz Fargas E, Obeso Inchausti J, Olivares Romero J, Olivé Plana J, Otermin Vallejo P, Pascual Sedano B, Pérez de Colosía Rama V, Pérez López-Fraile I, Planas Comes A, Puente Periz V, Rodríguez Oroz MC, Sevillano García D, Solís Pérez P, Suárez Muñoz J, Vaamonde Gamo J, Valero Merino C, Valldeoriola Serra F, Velázquez Pérez JM, Yáñez Baña R, Zamarbide Capdepon I.

Mov Disord. 2008 Jun 15;23(8):1130-6. doi: 10.1002/mds.22063.

PMID:
18442107
15.

Diagnostic and therapeutic value of apomorphine in Parkinsonian patients.

Sharma JC, Macnamara L, Hasoon M, Vassallo M.

Int J Clin Pract. 2004 Nov;58(11):1028-32.

PMID:
15605666
16.

A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease.

Tyne HL, Parsons J, Sinnott A, Fox SH, Fletcher NA, Steiger MJ.

J Neurol. 2004 Nov;251(11):1370-4.

PMID:
15592733
17.

Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease.

Grandas F.

Expert Rev Neurother. 2013 Dec;13(12):1343-53. doi: 10.1586/14737175.2013.839235. Epub 2013 Oct 25. Review.

PMID:
24160681
18.

Apomorphine: an underutilized therapy for Parkinson's disease.

Poewe W, Wenning GK.

Mov Disord. 2000 Sep;15(5):789-94. Review.

PMID:
11009181
19.
20.

Literature review: intermittent subcutaneous apomorphine therapy in Parkinson's disease.

Factor SA.

Neurology. 2004 Mar 23;62(6 Suppl 4):S12-7. Review.

PMID:
15037666

Supplemental Content

Support Center